Current Status of Endothelin Receptor Antagonists in Pulmonary Arterial Hypertension: A Combined Study Results and Pharmacology-Based Review

Pulmonary arterial hypertension (PAH) affects a wide range of people globally and has a poor prognosis despite many advancements in available treatment options. Among the available treatments, endothelin receptor antagonists (ERA) are among the most widely used drugs. These drugs have been evaluated...

Descripción completa

Detalles Bibliográficos
Autores principales: Nahar, Shamsun, Kanda, Srishti, Chatha, Uzair, Odoma, Victor A, Pitliya, Aakanksha, AlEdani, Esraa M, Bhangu, Japneet K, Javed, Khalid, Manshahia, Prabhleen Kaur, Yu, Ann Kashmer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10467640/
https://www.ncbi.nlm.nih.gov/pubmed/37654961
http://dx.doi.org/10.7759/cureus.42748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10467640/
https://www.ncbi.nlm.nih.gov/pubmed/37654961
http://dx.doi.org/10.7759/cureus.42748

Ejemplares similares